Advancing Precision Oncology with AI at ASCO 2026

BostonGene is presenting new findings at ASCO 2026 that demonstrate how AI-powered models and comprehensive molecular profiling can help identify biomarkers, predict treatment response, and support more informed clinical decision-making in cancer care.

Discover the latest innovations shaping the future of precision oncology: https://bostongene.com/news-an....d-publications/news/

BostonGene Recognized for Advancing AI in Oncology Drug Development

BostonGene has been honored as Innovator of the Year at the 2025 Life Sciences Times Vanguard Awards for its AI foundation models focused on improving oncology drug development. By combining tumor and immune biology with multiomic data, the platform helps biopharma organizations enhance clinical trial strategies, improve treatment predictions and support more efficient R&D decision making.

Read full announcement: https://bostongene.com/news-an....d-publications/news/

BostonGene and Hokkaido University Advance Precision Oncology Research

BostonGene has expanded its strategic research collaboration with Hokkaido University to support advancements in precision oncology. The partnership combines AI-powered molecular and immune profiling with clinical research expertise to better understand patient-specific disease biology across multiple cancer types and help guide more personalized treatment approaches.

Read the full announcement: https://bostongene.com/news-an....d-publications/news/

AI Is Changing Cancer Research and Drug Development

AI-powered healthcare technologies are helping researchers improve cancer studies by supporting smarter treatment planning, better patient selection, and more informed clinical trial decisions. By analyzing large volumes of medical and biological data, these tools are making drug development faster, more efficient, and increasingly data-driven.

Read more: https://bostongene.com/news-an....d-publications/news/

Understanding Human Biology Through AI and Multiomics Research

BostonGene and Unilever are working together to study how AI and integrated data approaches can reveal patterns in human biology. This collaboration reflects a broader shift toward using advanced analytics in scientific exploration.

Explore how data driven research is shaping new ways of understanding biology here: https://bostongene.com/news-an....d-publications/news/